Prognosis
Africa Left With Few Options for Vaccines, South Africa Says
- Pfizer offers to supply 50 million doses for health workers
- Moderna, AstraZeneca have no vaccines available for Africa
This article is for subscribers only.
Africa has few options to procure Covid-19 vaccines as the outbreak of the disease worsens across many parts of the continent, South Africa’s presidency said.
Pfizer Inc. and BioNTech SE have offered to supply Africa with 50 million Covid-19 vaccines for health workers between March and the end of this year, the presidency said in a response to Bloomberg on Sunday. Moderna Inc. has no supplies for Africa, while AstraZeneca Plc has no shots for the continent in 2021 and has directed the African Union to negotiate with the Serum Institute of India Ltd., which is making the vaccine on behalf of AstraZeneca. South Africa’s President Cyril Ramaphosa is the African Union’s chairman.